NCT00181610View on ClinicalTrials.gov

Recombinant Human Prolactin for Lactation Induction

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Lactation
Interventions
DRUG

Recombinant Human Prolactin

60 mcg/kg every 12 hours

BIOLOGICAL

Recombinant human prolactin

60 mcg/kg given every 12 hours or every 24 hours

BIOLOGICAL

Normal Saline

twice per day

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT00181610 - Recombinant Human Prolactin for Lactation Induction | Biotech Hunter | Biotech Hunter